共 72 条
[11]
Rasmussen S(2006)Dispelling myths and removing barriers about insulin in type 2 diabetes Diabetes Educ 32 9S-373
[12]
Bergenstal RM(2015)Creating and using real-world evidence to answer questions about clinical effectiveness J Innov Health Inf 22 368-335
[13]
Meneghini L(2017)Using real-world data for coverage and payment decisions: the ISPOR Real-World Data Task Force report Value Health 10 326-697
[14]
Atkin SL(2018)A European, multicentre, retrospective, non-interventional study (EU-TREAT) of the effectiveness of insulin degludec after switching basal insulin in a population with type 1 or type 2 diabetes Diabetes Obes Metab 20 689-58
[15]
Gough SC(2017)Real-life experience of patients starting insulin degludec. A multicenter analysis of 1064 subjects from the German/Austrian DPV registry Diabetes Res Clin Pract 29 52-10
[16]
Onishi Y(2016)A 1-year, prospective, observational study of Japanese outpatients with type 1 and type 2 diabetes switching from insulin glargine or detemir to insulin degludec in basal-bolus insulin therapy (Kumamoto Insulin Degludec Observational study) J Diabetes Investig 7 3-1055
[17]
Iwamoto Y(2017)Improved glycemic control achieved by switching to insulin degludec in insulin-treated patients with type 2 diabetes in a real-world setting: a non-interventional, retrospective cohort study Diabetes Ther 8 1047-2158
[18]
Yoo SJ(2018)Clinical outcomes in real-world patients with type 2 diabetes switching from first- to second-generation basal insulin analogues: comparative effectiveness of insulin glargine 300 units/mL and insulin degludec in the DELIVER D+ cohort study Diabetes Obes Metab 20 2148-110
[19]
Clauson P(2016)Inpatient hyperglycemia management: the opportunities of a new basal insulin Ital J Med 10 103-undefined
[20]
Tamer SC(undefined)undefined undefined undefined undefined-undefined